Andrew von Eschenbach, the former FDA commissioner, is now an advisor at Newt Gingrinch's Center for Health Transformation, reports the Wall Street Journal's Health Blog. He will lead a project that aims to modernize FDA by increasing its effectiveness and to speed the approval of new drugs.
Also on the FDA front, the agency is looking into health information found on the Internet, the Health Blog adds. A hearing in November will address "regulations to promotion in these newer media. FDA is evaluating how the statutory provisions, regulations, and policies concerning advertising and promotional labeling should be applied to product-related information on the Internet and newer technologies," according to the Federal Register.